Package 59762-2350-6

{"route": ["ORAL"], "spl_id": "51ec0774-2e64-4b64-8da7-7672e6e77736", "openfda": {"nui": ["N0000175753", "N0000008486"], "unii": ["5SEH9X1D1D"], "rxcui": ["251322"], "spl_set_id": ["19c924c2-f558-4c78-9277-2d7e0df2f505"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (59762-2350-6)  / 474 mL in 1 BOTTLE, PLASTIC", "package_ndc": "59762-2350-6", "marketing_start_date": "20200221"}, {"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (59762-2350-7)  / 474 mL in 1 BOTTLE, PLASTIC", "package_ndc": "59762-2350-7", "marketing_start_date": "20220701"}], "brand_name": "Ethosuximide", "product_id": "59762-2350_51ec0774-2e64-4b64-8da7-7672e6e77736", "dosage_form": "SOLUTION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "59762-2350", "generic_name": "Ethosuximide", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ethosuximide", "active_ingredients": [{"name": "ETHOSUXIMIDE", "strength": "250 mg/5mL"}], "application_number": "ANDA080258", "marketing_category": "ANDA", "marketing_start_date": "20200221", "listing_expiration_date": "20261231"}